- Country: Ukraine
- Summary: Cefoperazone/Sulbactam, Powder for Injections/Infusions 1G/1G; Ornidazole Solution for Infusions, 5 Mg/Ml, 100 Ml Each; Olimel N7E Emulsion for Infusions 1500 Ml; Olimel N9E Emulsion for Infusions 1500 Ml; Querce...
- UAT Ref No: 128487179
- Deadline: 22 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 766674.64
- Notice Type: Tender
- Document Ref. No.: UA-2025-10-17-012024-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Cefoperazone/Sulbactam, powder for injections/infusions 1g/1g; Ornidazole solution for infusions, 5 mg/ml, 100 ml each; Olimel N7E emulsion for infusions 1500 ml; Olimel N9E emulsion for infusions 1500 ml; Quercetin lyophilisate for solution for injection 0.5 g; Potassium asparaginate/Magnesium asparaginate solution for injections of 10 ml; Betamethasone suspension for injection, 7 mg/ml per 1 ml; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; Ketorolac solution for injection, 30 mg/ml, 1 ml each; Electrolytes in combination with Sorbitol 60 mg/1 ml of solution for infusions of 200 ml; Vitamin B1/B6/B12, solution for injection, 50 mg/50 mg/0.5 mg/1 ml, 2 ml each; Albumin, solution for infusions, 20%, 100 ml each; Nadroparin, solution for injection, 9500 IU anti-Xa/ml, 0.3 ml each; Carbamazepine 200 mg tablets; Cefotaxime, powder for injections of 1 g; Ibuprofen solution for infusions 4 mg/ml per 100 ml; Gentamicin, solution for injection, 40 mg/ml, 2 ml each; Calcium gluconate solution for injection 100 mg/ml in 5 ml; Protamine, solution for injection, 1000 IU/ml, 10 ml each; Hydroxyethyl starch (average molecular weight 200,000), 6%, 400 ml each Purchase type: Goods DK 021:2015:33600000-6: Pharmaceutical products Cefoperazone/Sulbactam, powder for injection/infusion 1g/1g, Ornidazole solution for infusion, 5 mg/ml, 100 ml each, Olimel N7E emulsion for infusions 1500 ml, Olimel N9E emulsion for infusions 1500 ml, Quercetin lyophilisate for solution for injections 0.5 g each, Potassium asparaginate/Magnesium asparaginate solution for injections 10 ml each, Betamethasone suspension for injections, 7 mg/ml each 1 ml, Diphenhydramine, solution for injection, 10 mg/ml, 1 ml, Ketorolac solution for injection, 30 mg/ml, 1 ml, Electrolytes in combination with Sorbitol 60 mg/1 ml solution for infusion, 200 ml, Vitamin B1/B6/B12, solution for injection, 50 mg/50 mg/0.5 mg/1 ml, each 2 ml, Albumin, solution for infusions, 20%, 100 ml each, Nadroparin, solution f...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCefoperazone/Sulbactam, Powder for Injections/Infusions 1G/1G; Ornidazole Solution for Infusions, 5 Mg/Ml, 100 Ml Each; Olimel N7E Emulsion for Infusions 1500 Ml; Olimel N9E Emulsion for Infusions 1500 Ml; Querce... - Ukraine Tender
The STATE INSTITUTION "INSTITUTE OF NEUROSURGERY NAMED AFTER ACADEMICIAN A.P. ROMODANOV OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE", a Government sector organization in Ukraine, has announced a new tender for Cefoperazone/Sulbactam, Powder for Injections/Infusions 1G/1G; Ornidazole Solution for Infusions, 5 Mg/Ml, 100 Ml Each; Olimel N7E Emulsion for Infusions 1500 Ml; Olimel N9E Emulsion for Infusions 1500 Ml; Querce.... This tender is published on UkraineTenders under UAT Ref No: 128487179 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-22.
The estimated tender value is UAH 766674.64, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
